IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $685,774 | -7.1% | 112,238 | -2.8% | 0.02% | -21.4% |
| Q4 2022 | $738,211 | +1.0% | 115,526 | +50.8% | 0.03% | +16.7% |
| Q3 2022 | $731,000 | -21.7% | 76,629 | -9.5% | 0.02% | -14.3% |
| Q2 2022 | $934,000 | -12.6% | 84,639 | +31.8% | 0.03% | 0.0% |
| Q1 2022 | $1,069,000 | +4.4% | 64,205 | +19.6% | 0.03% | +3.7% |
| Q4 2021 | $1,024,000 | -34.1% | 53,665 | -14.8% | 0.03% | -42.6% |
| Q3 2021 | $1,553,000 | -11.6% | 62,985 | -6.7% | 0.05% | -11.3% |
| Q2 2021 | $1,756,000 | +68.0% | 67,485 | +104.5% | 0.05% | +51.4% |
| Q1 2021 | $1,045,000 | -31.8% | 33,008 | 0.0% | 0.04% | -43.5% |
| Q4 2020 | $1,532,000 | +10.9% | 33,008 | -21.4% | 0.06% | -10.1% |
| Q3 2020 | $1,382,000 | +4.8% | 41,989 | -12.7% | 0.07% | 0.0% |
| Q2 2020 | $1,319,000 | -26.1% | 48,076 | -19.5% | 0.07% | -41.0% |
| Q1 2020 | $1,786,000 | +5.1% | 59,687 | -2.8% | 0.12% | +11.4% |
| Q4 2019 | $1,700,000 | +28.1% | 61,423 | -15.8% | 0.10% | -9.5% |
| Q3 2019 | $1,327,000 | -27.8% | 72,917 | -2.8% | 0.12% | -21.6% |
| Q2 2019 | $1,839,000 | +23.6% | 75,000 | -52.1% | 0.15% | +85.0% |
| Q1 2019 | $1,488,000 | +4.0% | 156,495 | -3.2% | 0.08% | 0.0% |
| Q4 2018 | $1,431,000 | -29.1% | 161,657 | -9.9% | 0.08% | +1.3% |
| Q3 2018 | $2,019,000 | -18.0% | 179,479 | -6.7% | 0.08% | -18.6% |
| Q2 2018 | $2,463,000 | -20.6% | 192,419 | -8.5% | 0.10% | -23.0% |
| Q1 2018 | $3,102,000 | +153.0% | 210,330 | +37.3% | 0.13% | +129.1% |
| Q4 2017 | $1,226,000 | -14.8% | 153,194 | -17.5% | 0.06% | -29.5% |
| Q3 2017 | $1,439,000 | +5.5% | 185,628 | 0.0% | 0.08% | -31.0% |
| Q2 2017 | $1,364,000 | – | 185,628 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |